@article{25463, keywords = {Mycobacterium lepromatosis, Mycobacterium leprae, Molecular diagnosis, leprosy, Geographic medicine}, author = {Han X and Aung F and Choon SE and Werner B}, title = {Analysis of the Leprosy Agents Mycobacterium leprae and Mycobacterium lepromatosis in Four Countries.}, abstract = {

OBJECTIVES: To differentiate the leprosy agents Mycobacterium leprae and Mycobacterium lepromatosis and correlate them with geographic distribution and clinicopathologic features.

METHODS: Species-specific polymerase chain reactions were used to detect each bacillus in archived skin biopsy specimens from patients with leprosy from Brazil (n = 52), Malaysia (n = 31), Myanmar (n = 9), and Uganda (n = 4). Findings were correlated with clinical and pathologic data.

RESULTS: Etiologic species was detected in 46 of the 52 Brazilian patients, including 36 patients with M leprae, seven with M lepromatosis, and three with both bacilli. The seven patients with sole M lepromatosis all had tuberculoid leprosy, whereas only nine of the 36 patients infected with M leprae exhibited this type, and the rest were lepromatous (P < .001). All patients with dual infections had lepromatous leprosy. Of the nine patients from Myanmar, six were test positive: four with M leprae and two with M lepromatosis. Of the Malaysian and Ugandan patients, only M leprae was detected in 27 of the 31 Malaysians and two of the four Ugandans.

CONCLUSIONS: The leprosy agents vary in geographic distribution. Finding M lepromatosis in Brazil and Myanmar suggests wide existence of this newly discovered species. The leprosy manifestations likely vary with the etiologic agents.

}, year = {2014}, journal = {American journal of clinical pathology}, volume = {142}, pages = {524-32}, issn = {1943-7722}, url = {http://ajcp.oxfordjournals.org/content/ajcpath/142/4/524.full.pdf}, doi = {10.1309/AJCP1GLCBE5CDZRM}, language = {eng}, }